Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELAD in alcohol-induced liver decompensation
2012-005563-27Phase 3Completed
- Sponsor
- Vital Therapies, Inc.
- Start
- Jan 2013
- Countries
- 1
01
Overview
A Phase 3 trial of ELAD in alcoholic liver disease (ALD), sponsored by Vital Therapies, Inc.. Started Jan 2013; status: completed.
02
Drugs
ELAD
03
Conditions
alcoholic liver disease (ALD)
Beyond the preview
Go deeper on 2012-005563-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005563-27.